Chemotherapy for low-grade gliomas: emerging consensus on its benefits.
Wen
Patrick Y
PY
DeAngelis
Lisa M
LM
D024221:Antineoplastic Protocols / Q000592:standards; D001932:Brain Neoplasms / Q000188:drug therapy*; D015254:DNA Modification Methylases / Q000235:genetics; D045643:DNA Repair Enzymes / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D004358:Drug Therapy / Q000592:standards* / Q000706:statistics & numerical data* / Q000639:trends; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D017063:Outcome Assessment, Health Care; D011878:Radiotherapy / Q000592:standards / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D025521:Tumor Suppressor Proteins / Q000235:genetics
D025521:Tumor Suppressor Proteins; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes